Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Double-target CAR-T therapy vector for colon cancer, and construction method and application of double-target CAR-T therapy vector

A colon cancer, dual-target technology, used in applications, chemical instruments and methods, botanical equipment and methods, etc., to achieve good therapeutic effects, inhibit release, and reduce damage.

Inactive Publication Date: 2018-10-12
SHANGHAI YIHAO BIOTECH CO LTD
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The above patents are all related research on CAR-T cell therapy, but there is currently a lack of vectors or related research on dual-target CAR-T therapy for colon cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Double-target CAR-T therapy vector for colon cancer, and construction method and application of double-target CAR-T therapy vector
  • Double-target CAR-T therapy vector for colon cancer, and construction method and application of double-target CAR-T therapy vector
  • Double-target CAR-T therapy vector for colon cancer, and construction method and application of double-target CAR-T therapy vector

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0084] (1) Plasmid extraction

[0085] Preparation method of LB liquid medium: Weigh 5g liquid medium dry powder into a 500mL Erlenmeyer flask with an electronic balance, add 100mL ultrapure water, seal with tin foil, sterilize in a high-pressure steam sterilizer, and cool to 40°C~ At 50°C, add 0.2% ampicillin at a ratio of 1000:1, mix carefully, transfer to a clean 500mL reagent bottle for later use, and store at 4°C.

[0086] The preparation method of LB solid medium: Weigh 5g solid medium dry powder into a 500mL Erlenmeyer flask with an electronic balance, add 100mL ultrapure water, seal it with tin foil, sterilize it in a high-pressure steam sterilizer, and cool it to 40°C~ At 50°C, add 0.2% ampicillin at a ratio of 1000:1, mix carefully, invert the plate, and after solidification, stick a parafilm and store at 4°C.

[0087] Take out the glycerol bacteria from the -80°C refrigerator. The glycerol bacteria contain lentiviral expression plasmids pCDH-EF1α-MCS-(PGK-Puro) and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a double-target CAR-T therapy vector for colon cancer, and a construction method and application of the double-target CAR-T therapy vector. The double-target CAR-T therapy vector consists of two parts comprising a lentiviral expression vector pCDH-EF1aplpha-MCS-(PGK-Puro) and a CAR structure. The specific structure of the CAR is Igkappa-iRGD-CEAscFv-(G<4>S)<5>-Her-2scFv-CD8alpha-CD28-CD137-CD3zeta-T2A-CCL19. A T cell containing the therapy vector, namlely the CAR-T cell (Chimeric Antigen Receptor T-Cell), is obtained through the mode of virus infection, and the CAR-T cell can be used for targeted identification and killing of colon cancer cells by expressing the CAR structure.

Description

technical field [0001] The present invention relates to a CAR-T therapeutic vector, in particular to a dual-target CAR-T therapeutic vector for colon cancer and its construction method and application. Background technique [0002] Colon cancer is a malignant lesion of the colonic mucosal epithelium under the action of various carcinogenic factors such as environment or heredity, and is one of the common malignant tumors. In recent years, the morbidity and mortality in our country are on the rise. At present, the main treatment methods include surgery, chemotherapy, radiotherapy, and traditional Chinese medicine. However, the therapeutic effect of the above methods is limited, and the side effects are relatively large. Although the multidisciplinary team (MDT) diagnosis and treatment model based on surgery for colon cancer and immunotherapy are gradually playing an increasingly important role, they cannot achieve satisfactory results. The ability to specifically recognize...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C12N15/867C12N5/10C12N5/0783A61K35/17A61P35/00
CPCA61K35/17C07K14/521C07K14/7051C07K16/3046C07K2319/00C12N5/0636C12N15/86C12N2510/00C12N2740/15043
Inventor 田晓丽
Owner SHANGHAI YIHAO BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com